Skip to main content
Premium Trial:

Request an Annual Quote

Tekmira Hits Milestone in Monsanto Deal

Premium

NEW YORK (GenomeWeb) – Tekmira Pharmaceuticals announced last week that it has received a $1.5 million milestone payment from ag-bio giant Monsanto.

In January, Tekmira announced that it signed a licensing deal giving Monsanto an option to license its proprietary lipid-based RNAi delivery technology for use in agricultural applications. Over the four-year term of the arrangement, Tekmira is providing Monsanto with lipid formulations in exchange for undisclosed payments to maintain the option. If Monsanto chooses to exercise its option, it will pay an undisclosed fee to Tekmira and receive an exclusive, worldwide license to its delivery technology in agriculture.

According to Tekmira, it has completed certain undisclosed program objectives, triggering the milestone payment. The company has previously received $16 million in milestones from Monsanto.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.